Michel Vounatsos
Direttore/Membro del Consiglio presso REVVITY, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
Michel Vounatsos è nel consiglio di amministrazione di PerkinElmer, Inc. (Stati Uniti), LInstitut de RYthmologie et Modlisation Cardiaque e n-Lorem Foundation e Chief Executive Officer & Director presso Biogen, Inc. Nella sua carriera passata ha occupato la posizione di Presidente-Primary Care & Customer Business Line presso Merck & Co., Inc. Il signor Vounatsos ha conseguito un MBA presso la cole des Hautes tudes Commerciales di Parigi.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REVVITY, INC.
0.01% | 01/05/2024 | 9 285 ( 0.01% ) | 1 M $ | 31/05/2024 |
ZAI LAB LTD.
0.04% | 18/06/2024 | 395 850 ( 0.04% ) | 740 762 $ | 31/05/2024 |
Posizioni attive di Michel Vounatsos
| Società | Posizione | Inizio |
|---|---|---|
| REVVITY, INC. | Direttore/Membro del Consiglio | 01/03/2020 |
| ZAI LAB LIMITED | Direttore/Membro del Consiglio | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Amministratore Delegato | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Amministratore Delegato | - |
| L’Institut de RYthmologie et Modélisation Cardiaque | Presidente | - |
| n-Lorem Foundation | Direttore/Membro del Consiglio | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michel Vounatsos
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Amministratore Delegato | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formazione di Michel Vounatsos
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| REVVITY, INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
| L’Institut de RYthmologie et Modélisation Cardiaque | |
| n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |
- Borsa valori
- Insiders
- Michel Vounatsos
